Covance Will Soon Be Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.


End-to End Support to Advance Gene Therapies for Rare Retinal Diseases

As a promising therapeutic candidate targeting rare inherited retinal diseases was spun out of an academic medical center, Covance served an integral role performing analytical testing of their product and ensure the project followed an expedited timeline.